FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)
Clinical trial NCT07621497 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07621497
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-06-01
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.